U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

DEPRODONE

MORE DETAILS

  Z380L7N00P

Status:
Possibly Marketed Outside US
Source:
ECLAR
Source URL:
http://adisinsight.springer.com/drugs/800006234
Class (Stereo):
CHEMICAL (ABSOLUTE)
Conditions:
Inflammatory skin diseases
5
Deprodone is a steroid that was approved in Japan for the treatment of inflammatory skin disorders. The drug is marketed under the name Eclar and contains 0.3% of the prodrug, deprodone propionate.

DEPRODONE PROPIONATE

MORE DETAILS

  S377ZHW5OE

Status:
Possibly Marketed Outside US
Source:
ECLAR
Source URL:
http://adisinsight.springer.com/drugs/800006234
Class (Stereo):
CHEMICAL (ABSOLUTE)
Conditions:
Inflammatory skin diseases
5
Deprodone is a steroid that was approved in Japan for the treatment of inflammatory skin disorders. The drug is marketed under the name Eclar and contains 0.3% of the prodrug, deprodone propionate.
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966